Literature DB >> 25278028

Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells.

Felix J Hartmann1, Mohsen Khademi2, Jehan Aram3, Sandra Ammann1, Ingrid Kockum2, Cris Constantinescu3, Bruno Gran3, Fredrik Piehl2, Tomas Olsson2, Laura Codarri1, Burkhard Becher1.   

Abstract

Genome-wide association studies implicate dysregulation of immune mechanisms in the pathogenesis of multiple sclerosis (MS). Particularly, polymorphisms in genes involved in T helper (TH) cell differentiation are associated with risk of developing MS. However, the underlying mechanism by which these risk alleles influence MS susceptibility has remained elusive. Initiation of neuroinflammation in animal models of MS has been shown to be dependent on TH cell-derived granulocyte-macrophage colony-stimulating factor (GM-CSF). We here report association of GM-CSF expression by human TH cells with MS disease severity. GM-CSF is strongly induced by interleukin 2 (IL-2). We show that an MS-associated polymorphism in the IL-2 receptor alpha (IL2RA) gene specifically increases the frequency of GM-CSF-producing TH cells. The IL2RA polymorphism regulates IL-2 responsiveness of naive TH cells and their propensity to develop into GM-CSF-producing memory TH cells. These findings mechanistically link an immunologically relevant genetic risk factor with a functional feature of TH cells in MS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25278028     DOI: 10.1038/ncomms6056

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  64 in total

1.  GM-CSF is not essential for experimental autoimmune encephalomyelitis but promotes brain-targeted disease.

Authors:  Emily R Pierson; Joan M Goverman
Journal:  JCI Insight       Date:  2017-04-06

Review 2.  Role of the β Common (βc) Family of Cytokines in Health and Disease.

Authors:  Timothy R Hercus; Winnie L T Kan; Sophie E Broughton; Denis Tvorogov; Hayley S Ramshaw; Jarrod J Sandow; Tracy L Nero; Urmi Dhagat; Emma J Thompson; Karen S Cheung Tung Shing; Duncan R McKenzie; Nicholas J Wilson; Catherine M Owczarek; Gino Vairo; Andrew D Nash; Vinay Tergaonkar; Timothy Hughes; Paul G Ekert; Michael S Samuel; Claudine S Bonder; Michele A Grimbaldeston; Michael W Parker; Angel F Lopez
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

Review 3.  Genetic basis of autoimmunity.

Authors:  Alexander Marson; William J Housley; David A Hafler
Journal:  J Clin Invest       Date:  2015-06-01       Impact factor: 14.808

4.  Aged hind-limb clasping experimental autoimmune encephalomyelitis models aspects of the neurodegenerative process seen in multiple sclerosis.

Authors:  Lindsay S Cahill; Monan Angela Zhang; Valeria Ramaglia; Heather Whetstone; Melika Pahlevan Sabbagh; Tae Joon Yi; Laura Woo; Thomas S Przybycien; Marina Moshkova; Fei Linda Zhao; Olga L Rojas; Josephine Gomes; Stefanie Kuerten; Jennifer L Gommerman; John G Sled; Shannon E Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-22       Impact factor: 11.205

Review 5.  Circulating immune cells in multiple sclerosis.

Authors:  A P Jones; A G Kermode; R M Lucas; W M Carroll; D Nolan; P H Hart
Journal:  Clin Exp Immunol       Date:  2016-11-02       Impact factor: 4.330

6.  Foxp3-independent mechanism by which TGF-β controls peripheral T cell tolerance.

Authors:  Soyoung A Oh; Ming Liu; Briana G Nixon; Davina Kang; Ahmed Toure; Michael Bivona; Ming O Li
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

7.  Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy.

Authors:  Javad Rasouli; Bogoljub Ciric; Jaime Imitola; Patricia Gonnella; Daniel Hwang; Kedar Mahajan; Elisabeth R Mari; Farinaz Safavi; Thomas P Leist; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

8.  Gatekeeper role of brain antigen-presenting CD11c+ cells in neuroinflammation.

Authors:  Magdalena Paterka; Volker Siffrin; Jan O Voss; Johannes Werr; Nicola Hoppmann; René Gollan; Patrick Belikan; Julia Bruttger; Jérôme Birkenstock; Steffen Jung; Enric Esplugues; Nir Yogev; Richard A Flavell; Tobias Bopp; Frauke Zipp
Journal:  EMBO J       Date:  2015-11-26       Impact factor: 11.598

Review 9.  Dendritic cells as therapeutic targets in neuroinflammation.

Authors:  Felix Luessi; Frauke Zipp; Esther Witsch
Journal:  Cell Mol Life Sci       Date:  2016-03-12       Impact factor: 9.261

Review 10.  Immunopathology of multiple sclerosis.

Authors:  Calliope A Dendrou; Lars Fugger; Manuel A Friese
Journal:  Nat Rev Immunol       Date:  2015-08-07       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.